|
Title
|
|
|
|
2-(2-oxo-morpholin-3-yl)-acetamide derivatives as broad-spectrum antifungal agents
| |
|
Author
|
|
|
|
| |
|
Abstract
|
|
|
|
| From a fungicidal screen, we identified 2-(2-oxo-morpholin-3-yl)- acetamide derivatives as fungicidal agents against Candida species, additionally characterized by antifungal activity against Aspergillus species. However, development of this series was hampered by low plasmatic stability. Introduction of a gemdimethyl on the 6-position of the morpholin-2-one core led to considerable improvement in plasmatic stability while maintaining in vitro antifungal activity. Further optimization of the series resulted in the discovery of N-(biphenyl-3- ylmethyl)-2-(4-ethyl-6,6-dimethyl-2-oxomorpholin-3-yl)acetamide (87), which, in addition to fungicidal activity against Candida species, shows promising and broad antifungal in vitro activity against various fungi species, such as molds and dermatophytes. In vivo efficacy was also demonstrated in a murine model of systemic Candida albicans infection with a significant fungal load reduction in kidneys. |
| |
|
Language
|
|
|
|
English
| |
|
Source (journal)
|
|
|
|
Journal of medicinal chemistry. - Washington, D.C., 1963, currens
| |
|
Publication
|
|
|
|
Washington, D.C.
:
2015
| |
|
ISSN
|
|
|
|
0022-2623
[print]
1520-4804
[online]
| |
|
DOI
|
|
|
|
10.1021/JM501814X
| |
|
Volume/pages
|
|
|
|
58
:3
(2015)
, p. 1502-1512
| |
|
ISI
|
|
|
|
000349573800038
| |
|
Pubmed ID
|
|
|
|
25585716
| |
|
Full text (Publisher's DOI)
|
|
|
|
| |
|
Full text (open access)
|
|
|
|
| |
|
Full text (publisher's version - intranet only)
|
|
|
|
| |
|